Vascular risk and FDDNP-PET influence cognitive performance

Manuscript Number: 

12-1903R2

Author(s): 
Jorge R. Barrio, Susan Y. Bookheimer, Linda M. Ercoli, Vladimir Kepe, Helen Lavretsky, David A. Merrill, Karen J. Miller, Pushpa V. Raja, Nathan Saito, Prabha Siddarth, Gary W. Small

Disclosures

Jorge R. Barrio

  • Nothing to Disclose

Susan Y. Bookheimer

  • Consulting Fees:
    Takeda Corp, consulting, < 5,000

Linda M. Ercoli

  • Consulting Fees:
    Motion Picture and Television Home 2012
    Lecture Fees:
    Travel expenses paid only Assisted Living Concepts May 2012

Vladimir Kepe

  • Nothing to Disclose

Helen Lavretsky

  • Consulting Fees:
    Lilly Pharma, Dey Pharma
    Grants
    • Agency: 
      Forest Laboratories
      Dates: 
      04/10-12/14

David A. Merrill

  • Nothing to Disclose

Karen J. Miller

  • Nothing to Disclose

Pushpa V. Raja

  • Nothing to Disclose

Nathan Saito

  • Nothing to Disclose

Prabha Siddarth

  • Nothing to Disclose

Gary W. Small

  • Consulting Fees:
    Dakim, Lilly, Novartis, Pfizer, Janssen
    Equity:
    Dakim
    Lecture Fees:
    Novartis
    Patents/Royalties
    Disclosure statement The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled ̢���Methods for Labeling Beta-Amyloid Plaques and Neurofibrillary Tangles,̢����_ that uses the approach outlined in this article. I am among the inventors, have received royalties, and may receive royalties on future sales
    Grants
    • Agency: 
      POM Wonderful
      Dates: 
      2012-2013